Effect of Cathodal Transcranial Direct Current Stimulation for Lower Limb Subacute Stroke Rehabilitation
Table 1
Baseline demographic and clinical characteristics.
Characteristic
Mean (SD)/median (IQR)
value
Trial group ()
Control group ()
Age (y)
65.83 (8.8)
66.58 (10.3)
0.708
Male (no., %)
24 (52.2)
17 (37.8)
0.168
Weight (kg)
65 (60.0, 75.0)
64 (56.5, 70.0)
0.233
Medical history (no., %)
Currently smoking
15 (32.6)
20 (44.4)
0.246
Diabetes
23 (50.0)
26 (57.8)
0.457
Myocardial infarction
12 (26.1)
9 (20.0)
0.491
Atrial fibrillation
17 (37.0)
16 (35.6)
0.889
Hypertension
40 (87.0)
35 (77.8)
0.250
Medication (no., %)
Antiplatelet drug
43 (93.5)
43 (95.6)
0.664
Antihypertensive drugs
34 (73.9)
29 (64.4)
0.328
Hypoglycemic drug (hypoglycemic)
20 (43.5)
28 (62.2)
0.073
Lipid-lowering drugs (lipid-lowering)
16 (35.6)
11 (24.4)
0.250
Months poststroke (w)
5.0 (3.0, 7.0)
4.0 (2.0, 6.0)
0.071
NIHSS ()
6.41 (3.4)
6.84 (4.2)
0.594
Abbreviations: NIHSS: National Institutes of Health Stroke Scale. Two groups shared the same overall characteristics as listed without significant differences between the groups ().
